Dear All, WHO are looking for multidisciplinary university groups or other scientific institutions to support the development of a One Health Priority Research Agenda on AMR! Per the RFP on the UN website (https://www.ungm.org/Public/Notice/146908), the terms of reference include scientific and methodological support for the following activities: Review of the grey literature and policy analysis of
Dear All, WHO are working steadily to maintain a comprehensive view of the clinical and preclinical pipelines. Such reports are invaluable in showing policymakers the need for continue Push/Pull in this area. Their 2020 clinical & pre-clinical antibacterial pipeline report was released in April of this year and discussed in detail in a 14 Apr 2021
Dear All, WHO have today updated their 2019 clinical/preclinical pipeline review by releasing their 2020 analyses of both the clinical and pre-clinical antibacterial product pipelines (the new 2020 report, the press release). Their 2020 review of antibacterial products in Phase 1 and beyond covers both traditional (n = 43) and non-traditional products (n = 27)
Dear All, What a wild day … it feels like the flood gates have opened! I am still smiling about the amazing BARDA announcement of 10 further years of funding for an Antibacterial Accelerator! In parallel, six (6!) contractor/job openings have popped onto my radar! Three are with WHO and three are with the recently created
Dear All, Just now posted is an excellent opportunity to be a full-time Team Lead at WHO in the AMR group with Peter Beyer. Here’s the link you need: https://careers.who.int/careersection/ex/jobdetail.ftl?job=2100011 In brief, this is a very visible and senior Team Lead role with a top-level job description of “Develops and proposes innovative technical health policies
Dear All, Two brief items today: First, a survey on OneHealth research priorities from WHO/FAO/OIE: “The Tripartite collaboration between World Health Organization (WHO), Food and Agricultural Organization of the United Nations (FAO), and World Organization for Animal Health (OIE)) is joining efforts to develop a One Health priority research agenda on antimicrobial resistance (AMR). “This
Dear All, WHO’s GLASS Secretariat (Global Antimicrobial Resistance Surveillance System, link) have recently released a standardized method for estimating attributable mortality of antimicrobial resistant bloodstream infections. The webpage discussing the document is here; the document itself is here. GLASS currently collects surveillance data on infections in the blood as well as the urinary, gastrointestinal, and
Dear All, Just below my signature, you will find the details of WHO’s search for a consultant to help them create the global governance for AMR-related work. Sorting through the acronyms takes a bit of effort, but this role will sit at the heart of the global OneHealth agenda of the UN IACG (Interagency Coordination
Dear All, WHO have been thinking about the threat of resistant fungi as well as resistant bacteria. An initial discussion by a small working group on approaches to priority fungal pathogens (April 2020, here’s the link to the report) concluded that Candida auris; azole-resistant Candida spp., azole-resistant Aspergillus fumigatus, Cryptococcus neoformans (& C. gattii), Pneumocystis jirovecii, Mucorales, and potentially Histoplasmosis were
Dear All, See below my signature: A 6-month consultancy with WHO to support the the SECURE initiative, a program to assist countries in accessing and sustainably managing new and existing antibiotics needed to cope with antimicrobial resistance (AMR). There’s not much online (yet) about SECURE: the best description I can find is in the Terms of Reference
